The main criterion in assessing the therapeutic efficacy of tissue engineered construct is the successful restoration of the host's physiology. Direct and non-invasive in vivo monitoring of a construct is of great importance for the following reasons: it provides correlations between construct function and physiologic effects post-implantation in vivo; and it offers the possibility of assessing changes in construct function that may be used to develop early markers of construct failure in advance of the end-point effects. The overall objective of the proposed research is to develop a noninvasive methodology to monitor in vivo the function of an implanted tissue engineered pancreatic substitute. NMR is uniquely suited to perform such studies since it is a non-invasive modality that has the ability to probe into the intracellular metabolism of the construct, and to view the anatomy of the host at the site of implantation. NMR spectroscopic and imaging techniques can monitor several intracellular and extracellular metabolites without necessitating the introduction of foreign agents or the fixation of cells. It is our hypothesis that NMR detectable metabolic indexes can be used to monitor the function of an implanted tissue engineered pancreatic substitute and provide early indicators of implant failure while the recipient is still euglycemic. The NMR nuclei examined in this study include 1H, 19F and 31P, while the model pancreatic construct utilized is composed of mouse insulinoma #TC-tet cells or mouse islets encapsulated in alginate/poly-L- lysine/alginate beads and contained within an agarose matrix that allows for easy retrieval. The following Specific Aims are designed to address our hypothesis:
Specific Aim 1 : To optimize in vivo NMR signal acquisition with inductively coupled RF-coils.
Specific Aim 2 : To develop and validate a model of time-dependent oxygen and cell density gradients within constructs.
Specific Aim 3 : To non-invasively assess the function of an implanted tissue engineered pancreatic substitute and correlate that to end point physiologic events. We believe this to be a thorough, quantitative and a significant study to monitor the function of an implanted tissue engineered substitute that will identify metabolic events associated with failure ahead of its end physiologic effect. Proposed experiments are founded on strong preliminary data and we are confident that they will pave the way for further imaging studies in tissue engineering. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK047858-12
Application #
7492255
Study Section
Musculoskeletal Tissue Engineering Study Section (MTE)
Program Officer
Appel, Michael C
Project Start
1995-03-01
Project End
2011-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
12
Fiscal Year
2008
Total Cost
$265,099
Indirect Cost
Name
University of Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Goh, Fernie; Long Jr, Robert; Simpson, Nicholas et al. (2011) Dual perfluorocarbon method to noninvasively monitor dissolved oxygen concentration in tissue engineered constructs in vitro and in vivo. Biotechnol Prog 27:1115-25
Goh, Fernie; Sambanis, Athanassios (2011) In vivo noninvasive monitoring of dissolved oxygen concentration within an implanted tissue-engineered pancreatic construct. Tissue Eng Part C Methods 17:887-94
Volland, Nelly A; Mareci, Thomas H; Constantinidis, Ioannis et al. (2010) Development of an inductively coupled MR coil system for imaging and spectroscopic analysis of an implantable bioartificial construct at 11.1 T. Magn Reson Med 63:998-1006
Goh, Fernie; Gross, Jeffrey D; Simpson, Nicholas E et al. (2010) Limited beneficial effects of perfluorocarbon emulsions on encapsulated cells in culture: experimental and modeling studies. J Biotechnol 150:232-9
Constantinidis, Ioannis; Grant, Samuel C; Simpson, Nicholas E et al. (2009) Use of magnetic nanoparticles to monitor alginate-encapsulated betaTC-tet cells. Magn Reson Med 61:282-90
Gross, Jeffrey D; Constantinidis, I; Sambanis, A (2007) Modeling of encapsulated cell systems. J Theor Biol 244:500-10
Constantinidis, Ioannis; Grant, Samuel C; Celper, Susanne et al. (2007) Non-invasive evaluation of alginate/poly-l-lysine/alginate microcapsules by magnetic resonance microscopy. Biomaterials 28:2438-45
Simpson, Nicholas E; Grant, Samuel C; Gustavsson, Lenita et al. (2006) Biochemical consequences of alginate encapsulation: a NMR study of insulin-secreting cells. Biomaterials 27:2577-86
Oca-Cossio, Jose; Mao, Hui; Khokhlova, Nata et al. (2004) Magnetically labeled insulin-secreting cells. Biochem Biophys Res Commun 319:569-75
Simpson, Nicholas E; Grant, Samuel C; Blackband, Stephen J et al. (2003) NMR properties of alginate microbeads. Biomaterials 24:4941-8